ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.653,42
0,25%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Blue Water Biotech Inc (BWV)

  7. Blue Water Biotech Inc (BWV) News

BWV

Blue Water Biotech (BWV)

Blue Water Biotech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BWV
DatumZeitQuelleÜberschriftSymbolFirma
21/12/202322h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
19/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
19/12/202313h00GlobeNewswire Inc.Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to ShareholdersNASDAQ:BWVBlue Water Biotech Inc
18/12/202314h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
18/12/202313h00GlobeNewswire Inc.Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™NASDAQ:BWVBlue Water Biotech Inc
17/11/202323h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BWVBlue Water Biotech Inc
02/11/202312h00GlobeNewswire Inc.Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology CompanyNASDAQ:BWVBlue Water Biotech Inc
01/11/202312h00GlobeNewswire Inc.Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)NASDAQ:BWVBlue Water Biotech Inc
30/10/202314h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
30/10/202312h00GlobeNewswire Inc.Blue Water Biotech Issues Letter to ShareholdersNASDAQ:BWVBlue Water Biotech Inc
20/10/202323h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BWVBlue Water Biotech Inc
18/10/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
10/10/202315h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
10/10/202315h00GlobeNewswire Inc.Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFONASDAQ:BWVBlue Water Biotech Inc
03/10/202314h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
22/09/202322h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
08/09/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
28/08/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
28/08/202322h30GlobeNewswire Inc.Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-QNASDAQ:BWVBlue Water Biotech Inc
22/08/202323h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
15/08/202323h22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BWVBlue Water Biotech Inc
10/08/202315h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
10/08/202315h00GlobeNewswire Inc.Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial ProductsNASDAQ:BWVBlue Water Biotech Inc
03/08/202320h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
03/08/202319h02GlobeNewswire Inc.Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsNASDAQ:BWVBlue Water Biotech Inc
01/08/202314h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
01/08/202314h00GlobeNewswire Inc.Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsNASDAQ:BWVBlue Water Biotech Inc
31/07/202315h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
31/07/202315h00GlobeNewswire Inc.Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to PhysiciansNASDAQ:BWVBlue Water Biotech Inc
25/07/202315h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:BWV

Kürzlich von Ihnen besucht

COIN
SOLUSD
Solana
DBI
SDXP
SDAX
AMEX
XLF
Financial Select Sector
FX
EURGBP
Euro vs Sterling
TG
432
Arbor Metals
TG
TUI1
Tui
TG
MBG
MercedesBenz
TG
CBK
Commerzbank
NYSE
NKE
Nike
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
TG
LHA
Deutsche Lufthansa
USOTC
RHHBY
Roche (QX)
DBI
TDXP
Tec DAX
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten